These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3499970)

  • 1. Natural killer cells in children with acute leukemia. The effect of interleukin-2.
    Mageed AA; Findley HW; Franco C; Singhapakdi S; Alvarado C; Chan WC; Ragab AH
    Cancer; 1987 Dec; 60(12):2913-8. PubMed ID: 3499970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interleukin-2 activates peripheral blood lymphocytes from children with acute leukemia to kill autologous leukemic cells.
    Findley HW; Abdel Mageed A; Nasr SA; Ragab AH
    Cancer; 1988 Nov; 62(9):1928-31. PubMed ID: 3262410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
    Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
    Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
    Lotzová E; Savary CA; Herberman RB
    J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
    Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N; Müller-Ruchholtz W
    Leukemia; 1996 Nov; 10(11):1758-64. PubMed ID: 8892679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
    Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
    J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2.
    Kay NE; Zarling J
    Am J Hematol; 1987 Feb; 24(2):161-7. PubMed ID: 3028132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic and clinical aspects of natural killer cells in human leukemia.
    Lotzová E; Savary CA; Pollock RE; Fuchshuber P
    Nat Immun Cell Growth Regul; 1990; 9(3):173-81. PubMed ID: 2370877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of purified Leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia.
    Afify ZA; Abdel-Mageed A; Findley HW; Ragab AH
    Cancer; 1990 Aug; 66(3):469-73. PubMed ID: 1694716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer cell activity and cells expressing the Leu 7 and Leu 11b (CD 16) markers in the bone marrow of children in remission.
    Sørskaar D; Førre O; Tjønneland S; Lie SO
    Scand J Immunol; 1988 Jul; 28(1):11-7. PubMed ID: 3261034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
    Saghafi S; Pourfathollah AA; Kheirandish M; Azimdoust A; Behnia M; Shahjahani M; Moin M
    Iran J Allergy Asthma Immunol; 2010 Jun; 9(2):69-77. PubMed ID: 20683100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
    Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
    Sørskaar D; Førre O; Lie SO
    Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.
    Tajima F; Kawatani T; Endo A; Kawasaki H
    Leukemia; 1996 Mar; 10(3):478-82. PubMed ID: 8642865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y; Levanon M; Davidsohn J; Ramot B
    J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.
    Uchiyama T; Sato N; Narita M; Yamahira A; Iwabuchi M; Furukawa T; Sone H; Takahashi M
    Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
    Klingemann HG; Wong E; Maki G
    Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.